You are here:
Pre-Conference Session - Adverse Events through the Looking Glass Hot Topics Update - Adverse Events - Allan Bowditch - Ziment - USA and Dan Fitzgerald - GfK V2 - USA Adverse Events Guidelines Adverse Events Background Information Session 1 - New Business Models Financial Health of the Pharmaceutical industry: Wall Street's Perspective - Timothy Andersen - Prudential Equity Group - USA Parallel Universes - Charting Healthcare's Possible Futures - Kim Slocum - KDS Consulting - USA The Future Rx'ing Dilemma - Sarah Fuller and Jim McDermott - Decision Resources Inc - USA Unlocking Growth in China - Yehong Zhang - IMS Health - China Session 2 - Extending our Reach Boosting Brand Growth Now in Emerging Markets - Kurt Kessler - ZS Associates - USA Impact of PCP Beliefs on Future Pharma Marketing - Jackie Morgan - Adelphi International Research - UK The Epidemiology of Disease in Emerging Markets and Challenges to estimating Patient Populations: Focus on China - Michael McGuill and Nikhil Mehta - Decision Resources Inc - USA and UK Session 3 - Above and Beyond Improving the Accuracy and Flexibility of MR Models to Address Evolving Management Needs - John Tapper - Ziment - USA and Andrew Scott - Ziment - UK The Breast Cancer Journey......it's as vital as the air that they breathe......Julie Buis - Aequus Research - UK Leveraging Market Research Data for Outcome Research Publications - Michael Kelly - Consumer Health Sciences & imap Research - USA Session 4 - The Trial Is it Legal to Conduct Market Research? Defending Attorney: Stephen Godwin - Synovate Healthcare - UK Prosecutor: Allan Bowditch - Ziment - USA The Charge: Marketing research/intelligence is becoming fatally compromised due to legal battles about privacy, adverse event reporting and its changing role within the pharmaceutical marketing environment.
2007 CONFERENCE PHOTOS
http://www.lauphot.be/events
user name: ephmra password: 2007
Post Conference News - click here
?? Questions - contact here